122 related articles for article (PubMed ID: 9616550)
1. Metrotop: a topical antimicrobial agent for malodorous wounds.
Moody M
Br J Nurs; 1998 Mar 12-25; 7(5):286-9. PubMed ID: 9616550
[TBL] [Abstract][Full Text] [Related]
2. A topical metronidazole gel used to treat malodorous wounds.
Bale S; Tebbie N; Price P
Br J Nurs; 2004 Jun; 13(11):S4-11. PubMed ID: 15218439
[TBL] [Abstract][Full Text] [Related]
3. Topical metronidazole for the treatment of wound odor: a review of the literature.
Paul JC; Pieper BA
Ostomy Wound Manage; 2008 Mar; 54(3):18-27; quiz 28-9. PubMed ID: 18382045
[TBL] [Abstract][Full Text] [Related]
4. Early identification of wound infection: understanding wound odour.
Ousey K; Roberts D; Gefen A
J Wound Care; 2017 Oct; 26(10):577-582. PubMed ID: 28976829
[TBL] [Abstract][Full Text] [Related]
5. Case study: eliminating odors from wounds.
Poteete V
Decubitus; 1993 Jul; 6(4):43-6. PubMed ID: 8297491
[TBL] [Abstract][Full Text] [Related]
6. The effect of topical 0.75% metronidazole gel on malodorous cutaneous ulcers.
Finlay IG; Bowszyc J; Ramlau C; Gwiezdzinski Z
J Pain Symptom Manage; 1996 Mar; 11(3):158-62. PubMed ID: 8851373
[TBL] [Abstract][Full Text] [Related]
7. Improving malodour management in advanced cancer: a 10-year retrospective study of topical, oral and maintenance metronidazole.
George R; Prasoona TS; Kandasamy R; Cherian R; Celine T; Jeba J; Murali S; Mathew D
BMJ Support Palliat Care; 2017 Sep; 7(3):286-291. PubMed ID: 28174164
[TBL] [Abstract][Full Text] [Related]
8. Metronidazole gel in managing malodorous fungating wounds.
Clark J
Br J Nurs; 2002 Mar; 11(6 Suppl):S54-60. PubMed ID: 11979191
[TBL] [Abstract][Full Text] [Related]
9. Metronidazole use in malodorous skin lesions.
Rice TT
Rehabil Nurs; 1992; 17(5):244-5, 255. PubMed ID: 1448604
[TBL] [Abstract][Full Text] [Related]
10. The use of metronidazole in the treatment of malodorous wounds.
Hampson JP
J Wound Care; 1996 Oct; 5(9):421-5. PubMed ID: 8954436
[No Abstract] [Full Text] [Related]
11. A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours.
Bower M; Stein R; Evans TR; Hedley A; Pert P; Coombes RC
Eur J Cancer; 1992; 28A(4-5):888-9. PubMed ID: 1524917
[TBL] [Abstract][Full Text] [Related]
12. Use of metronidazole gel to control malodor in advanced and recurrent breast cancer.
Kuge S; Tokuda Y; Ohta M; Okumura A; Kubota M; Ninomiya S; Sawamura S; Makuuchi H; Tajima T; Mitomi T
Jpn J Clin Oncol; 1996 Aug; 26(4):207-10. PubMed ID: 8765176
[TBL] [Abstract][Full Text] [Related]
13. Anaerobic bacterial flora of wound sepsis.
Arora S; Prabhakar H; Garg BB; Jindal N
J Indian Med Assoc; 1990 Jun; 88(6):154-6. PubMed ID: 2230157
[TBL] [Abstract][Full Text] [Related]
14. Topical Metronidazole for Odor Control in Pressure Ulcers.
Lyvers E; Elliott DP
Consult Pharm; 2015 Sep; 30(9):523-6. PubMed ID: 26350892
[TBL] [Abstract][Full Text] [Related]
15. Recognising and treating the causes of chronic malodorous wounds.
Holloway S
Prof Nurse; 2004 Mar; 19(7):380-4. PubMed ID: 15027403
[TBL] [Abstract][Full Text] [Related]
16. Non-specific vaginitis: diagnostic features and response to imidazole therapy (metronidazole, ornidazole).
Meech RJ; Loutit J
N Z Med J; 1985 May; 98(779):389-91. PubMed ID: 3887255
[TBL] [Abstract][Full Text] [Related]
17. Topical metronidazole. Part II.
McMullen D
Ostomy Wound Manage; 1992 Apr; 38(3):42-6, 48. PubMed ID: 1580972
[No Abstract] [Full Text] [Related]
18. Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013).
Watanabe K; Shimo A; Tsugawa K; Tokuda Y; Yamauchi H; Miyai E; Takemura K; Ikoma A; Nakamura S
Support Care Cancer; 2016 Jun; 24(6):2583-90. PubMed ID: 26715293
[TBL] [Abstract][Full Text] [Related]
19. Using metronidazole (Flagyl) for odor control.
Melious N
Oncol Nurs Forum; 1995 Jul; 22(6):987-8. PubMed ID: 7567618
[No Abstract] [Full Text] [Related]
20. Malodour from oral malignant fungating wound: sprayed metronidazole - case report.
Harano H; Matsunuma R; Tanaka-Yagi Y; Ito M; Tasaki J; Egawa A; Yamaguchi T
BMJ Support Palliat Care; 2024 Jan; 13(e3):e966-e967. PubMed ID: 36944483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
